L
Lexicon Pharmaceuticals (LXRX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Lexicon Pharmaceuticals (LXRX)
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its pipeline includes Sotagliflozin, LX9211, and ... Read more
- USD1.07
- USD1.19
- USD1.07
- USD2.45
- 43.60%
- 31M
- 3.92M
- 4.51M
- 327M
- 0.28
- -33.10%
Stock News
1 hour ago
Top-Performing E-Commerce Stock MercadoLibre Falls As Trump Pledges 50% Brazil Tariffs
Yahoo
2 hours ago
Coffee prices rise on Trump tariff threat — plus, the winners in Thursday's market rotation
CNBC
2 hours ago
Can the S&P 500 hit 7,000 by year-end? One veteran Wall Street strategist says yes.
MarketWatch
3 hours ago
Space startup Varda raises $187 million in funding to make drugs in orbit
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
